Precede Biosciences Alternatives & Competitors
11 companies similar to Precede Biosciences — Precede Bio is impacting precision medicine with a first-in-class 🩸 liquid biop...
Companies similar to Precede Biosciences
Oncobit AG
Enabling personalized cancer care
Schlieren, Switzerland
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HG...
Waltham, United States
Foundation Medicine
A precision medicine company transforming lives in cancer and beyond.
Boston, United States
China
Rival Readout
Competing with Precede Biosciences? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Sunbird Bio
Unparalleled leader in protein-based diagnostic tests, empowering researchers and clinicia...
Cambridge, United States
Elevation Oncology
We are focused on discovering and developing selective cancer therapies to treat patients...
Boston, United States
OncoDNA
Genomic and theranostic company specializing in precision medicine for the treatment of ca...
Belgium
Treeline
Making medicines at the highest level
Watertown, United States
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Boston, United States
About Precede Biosciences
Precede Biosciences, founded in 2021, is at the forefront of precision medicine with its innovative first-in-class liquid biopsy platform. With headquarters in the United States, the company stands out for its commitment to enhance the medical community's understanding of disease-defining biology, offering a simple blo...
Liquid biopsy platform development, Epigenomic analysis and profiling, Diagnostics for cancer and other diseases, Therapeutic target identification, Strategic partnerships with pharmaceutical companies, R&D in precision medicine
Pharmaceutical companies, Biotech firms, Oncology research institutions, Healthcare providers, Medical diagnostic labs
Precision Medicine, Liquid Biopsy, Transcriptional Biology, Chromatin Profiling, DNA Methylome, Genomic Medicine, Diagnostic Tests, Drug Development, Cancer Diagnosis, Minimally Invasive Diagnostics, Disease Biology, Machine Learning In Genomics, Artificial Intelligence In Healthcare, Oncology, Genomic Profiling
B2B, DaaS, B2D
Service Fee, Licensing, Consulting Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Precede Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Precede Biosciences on 10 Apr 2026. The 11 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
